Literature DB >> 20098438

Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients.

P C Guest, L Wang, L W Harris, K Burling, Y Levin, A Ernst, M T Wayland, Y Umrania, M Herberth, D Koethe, J M van Beveren, M Rothermundt, G McAllister, F M Leweke, J Steiner, S Bahn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098438     DOI: 10.1038/mp.2009.81

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  40 in total

1.  Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis.

Authors:  Stefan Busse; Hans-Gert Bernstein; Mandy Busse; Hendrik Bielau; Ralf Brisch; Christian Mawrin; Susan Müller; Zoltán Sarnyai; Tomasz Gos; Bernhard Bogerts; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-14       Impact factor: 5.270

2.  Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients.

Authors:  Julian A J Jaros; Daniel Martins-de-Souza; Hassan Rahmoune; Emanuel Schwarz; F Markus Leweke; Paul C Guest; Sabine Bahn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-15       Impact factor: 5.270

3.  Proteomics as a tool for understanding schizophrenia.

Authors:  Daniel Martins-de-Souza
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-12-31       Impact factor: 2.582

Review 4.  Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders.

Authors:  Rita Barandas; Dominic Landgraf; Michael J McCarthy; David K Welsh
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 5.  Mitochondrial dysfunction in schizophrenia: an evolutionary perspective.

Authors:  Vanessa F Gonçalves; Ana C Andreazza; James L Kennedy
Journal:  Hum Genet       Date:  2014-10-14       Impact factor: 4.132

6.  Choroid Plexus Enlargement and Allostatic Load in Schizophrenia.

Authors:  Yan-Fang Zhou; Jun-Chao Huang; Ping Zhang; Feng-Mei Fan; Song Chen; Hong-Zhen Fan; Yi-Min Cui; Xing-Guang Luo; Shu-Ping Tan; Zhi-Ren Wang; Wei Feng; Ying Yuan; Fu-De Yang; Anya Savransky; Meghann Ryan; Eric Goldwaser; Joshua Chiappelli; Laura M Rowland; Peter Kochunov; Yun-Long Tan; L Elliot Hong
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

7.  Identification of targeted analyte clusters for studies of schizophrenia.

Authors:  Tammy M K Cheng; Yu-En Lu; Paul C Guest; Hassan Rahmoune; Laura W Harris; Lan Wang; Dan Ma; Victoria Stelzhammer; Yagnesh Umrania; Matt T Wayland; Pietro Lió; Sabine Bahn
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

8.  S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance.

Authors:  Johann Steiner; Aye Mu Myint; Kolja Schiltz; Sabine Westphal; Hans-Gert Bernstein; Martin Walter; Matthias L Schroeter; Markus J Schwarz; Bernhard Bogerts
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-10

Review 9.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

Review 10.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.